EODData

NASDAQ, LIMN: Liminatus Pharma Inc Cl A

10 Nov 25 05:32
LAST:

1.170

CHANGE:
 0.01
OPEN:
1.190
HIGH:
1.190
ASK:
0.000
VOLUME:
4.9K
CHG(%):
0.86
PREV:
1.160
LOW:
1.170
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
10 Nov 251.1901.1901.1701.1704.9K
07 Nov 251.2801.2801.1301.165397.5K
06 Nov 251.2901.3201.2401.280145.1K
05 Nov 251.2601.3501.2601.310159.1K
04 Nov 251.3201.3301.2001.270187.2K
03 Nov 251.4001.4001.3101.320282.6K
31 Oct 251.4501.4501.3521.390230.6K
30 Oct 251.4501.7001.3201.4101.05M
29 Oct 251.4001.5601.3101.420862.1K
28 Oct 251.2801.5501.2601.4201.39M

COMPANY PROFILE

Name:Liminatus Pharma Inc Cl A
About:Liminatus Pharma, Inc. operates as a pre-clinical stage biopharmaceutical company that develops novel cancer therapies. It is developing CD47, a high affinity humanized anti CD47 antibody that has the potential to translate into clinic for CD47 SIRPa blocking and restoring the anti-tumor function of innate immune cells without inducing hemagglutination or hemolysis. The company was founded in 2018 is based in LA Palma, California.
Sector:Healthcare
Industry:Biotechnology
Address:6 Centerpointe Drive, La Palma, CA, United States, 90623
Website:https://liminatuspharma.com
ISIN:US53271X1081
FIGI:BBG01HVYG111

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-6.89 
Price to Book:-32,395.58 
Return on Assets:-2.22 
Return on Equity:0.32 
EPS Ratio:-0.16 
Shares:27.06M 
Market Cap:31.67M 

TECHNICAL INDICATORS

MA5:1.245.9%
MA10:1.3212.4%
MA20:1.278.5%
MA50:1.6238.4%
MA100:4.39274.8%
STO9:0.93 
STO14:0.93 
RSI14:48.36
WPR14:-98.04 
ATR:0.16 
Week High:1.4019.7%
Week Low:1.133.5%
Month High:1.7045.3%
Month Low:1.11
Volatility:89.28